Increased prevalence of self-reported psychotic illness predicted by crystal methamphetamine use: Evidence from a high-risk population.

[1]  W. Hall,et al.  Crystalline methamphetamine use and methamphetamine‐related harms in Australia , 2017, Drug and alcohol review.

[2]  T. Dobbins,et al.  Estimating the number of regular and dependent methamphetamine users in Australia, 2002–2014 , 2016, The Medical journal of Australia.

[3]  J. Mørland,et al.  Amphetamine-induced psychosis: Transition to schizophrenia and mortality in a small prospective sample. , 2015, The American journal on addictions.

[4]  H. Whiteford,et al.  Stimulant use disorders in people with psychosis: A meta-analysis of rate and factors affecting variation , 2015, The Australian and New Zealand journal of psychiatry.

[5]  A. Baker,et al.  Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study. , 2013, JAMA psychiatry.

[6]  S. Pirkola,et al.  Substance-induced psychoses converting into schizophrenia: a register-based study of 18,478 Finnish inpatient cases. , 2013, The Journal of clinical psychiatry.

[7]  E. B. Rognli,et al.  Amphetamine-induced psychosis - a separate diagnostic entity or primary psychosis triggered in the vulnerable? , 2012, BMC Psychiatry.

[8]  G. Remington,et al.  Methamphetamine use and schizophrenia: a population-based cohort study in California. , 2012, The American journal of psychiatry.

[9]  P. Kittirattanapaiboon,et al.  Long-term outcomes in methamphetamine psychosis patients after first hospitalisation. , 2010, Drug and alcohol review.

[10]  R. Mcketin,et al.  The risk of psychotic symptoms associated with recreational methamphetamine use. , 2010, Drug and alcohol review.

[11]  A. Weinstein,et al.  Pharmacological approaches to methamphetamine dependence: a focused review. , 2010, British journal of clinical pharmacology.

[12]  R. Murray,et al.  Prevalence of psychotic symptoms in substance users: a comparison across substances. , 2009, Comprehensive psychiatry.

[13]  M. Hillhouse,et al.  Clinical course and outcomes of methamphetamine-dependent adults with psychosis. , 2008, Journal of substance abuse treatment.

[14]  J. McGrath,et al.  Schizophrenia: a concise overview of incidence, prevalence, and mortality. , 2008, Epidemiologic reviews.

[15]  R. Mcketin,et al.  Major physical and psychological harms of methamphetamine use. , 2008, Drug and alcohol review.

[16]  Peter B. Jones,et al.  Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review , 2007, The Lancet.

[17]  Leanne Hides,et al.  The prevalence of psychotic symptoms among methamphetamine users. , 2006, Addiction.

[18]  H. Häfner.  Gender differences in schizophrenia , 2003, Psychoneuroendocrinology.

[19]  R. Kessler,et al.  The performance of the K6 and K10 screening scales for psychological distress in the Australian National Survey of Mental Health and Well-Being , 2003, Psychological Medicine.

[20]  R. Kessler,et al.  Short screening scales to monitor population prevalences and trends in non-specific psychological distress , 2002, Psychological Medicine.

[21]  Raimondo Bruno,et al.  Australian Drug Trends 2004: Findings from the Illicit Drug Reporting System (IDRS) , 2006 .

[22]  R. Mattick,et al.  Choosing a cut-off on the Severity of Dependence Scale (SDS) for amphetamine users. , 1997, Addiction.

[23]  W. Hall,et al.  Psychological morbidity and route of administration among amphetamine users in Sydney, Australia. , 1996, Addiction.

[24]  C. O'brien,et al.  Crack cocaine abuse: an epidemic with many public health consequences. , 1996, Annual review of public health.

[25]  A. Cho.  Ice: A New Dosage Form of an Old Drug , 1990, Science.